The above point (2) provides evidence that loss of GLP-1 secretion with immediate pathophysiological consequences (reduced incretin effect as part of impaired postprandial beta cell function) calls for a replacement therapy with incretin-based glucose-lowering medications [3]
95% CI 0.90, 1.01)
Brand-name Wegovy follow-up visits are $100/month
On a cellular level, BPC-157 promotes the migration and survival of repair cells (fibroblasts, endothelial cells, etc.)
Saxenda, are approved for use in New Zealand as adjunctive treatments for weight loss, but none are currently funded for any indication Liraglutide administration guide 6, 8 Liraglutide is administered once daily, with or without food, at a consistent time each day Patients can inject liraglutide in the abdomen, thigh or upper arm (if assisted)
The injection is relatively simple and can be self-administered at home, following proper instructions from a healthcare professional